
Abera Bioscience Investor Relations Material
Latest events

Q1 2025
13 May, 2025

Q4 2024
13 Feb, 2025
Access the full event backlog
Slides, Transcripts, and Reports from 13,000 public companies
Latest reports from Abera Bioscience
Access all reports
Abera Bioscience AB is a Sweden-based biotechnology company specializing in vaccine development. The company focuses on creating next-generation vaccines using its proprietary platform technology, which is designed to enhance immune response and target a wide range of diseases. The company is headquartered in Solna, Sweden, and its shares are listed on the Spotlight Stock Market.